Did you hear about the doctor in Kentucky that just pleaded guilty to giving his patients research grade GLP-1s? It’s true, he’s facing up to 3 years in Federal prison for doing the same thing you may be doing. Find out how to source legit, legal compounded medications (GLP-1s and more) in this upcoming webinar…
According to this Medscape article, recent research is shining a spotlight on an unexpected benefit of GLP‑1 receptor agonists (GLP‑1 RAs) weight loss medications: they may help improve chronic inflammatory skin conditions, such as psoriasis, hidradenitis suppurativa (HS), and even wound healing . From Diabetes to Dermatology Originally developed to manage type 2 diabetes, GLP‑1 RAs (e.g., semaglutide,…
The surge in GLP-1 medications like semaglutide and tirzepatide is not only revolutionizing weight management but also reshaping the medical aesthetics industry. A recent McKinsey study has revealed that 63% of patients pursuing aesthetic treatments after starting GLP-1s had never received any aesthetics procedure before. These patients are entering the market with fresh…
Legal. Legit. Licensed. If you’re prescribing GLP-1s, make sure you’re doing it legally. At DrWell, were integrated with top-tier licensed 503A and 503B compounding pharmacies-never research-grade sources that could jeopardize your license. Sure, we’ve all received the emails with the great rates on “peptides” and GLP-1s. You may have thought access to some of these…
Weight and facial volume loss: Treating the whole patient with Tiger Aesthetics X DrWell Webinar on June 18th at 4p PST. Register here. As more patients use GLP-1 medications for weight loss, providers like you will increasingly encounter facial volume loss—whether they’re your own patients or referred by others. Position your practice to address…
Aesthetic Practice Partners are hosting their Medspa Business Accelerator on June 13th and 14th at Hotel Adeline in Scottsdale. You can purchase tickets here. On Friday June 13th, our very own Dr. Jonathan Kaplan, founder/CEO of DrWell will speak on the topic of launching and scaling a weight and wellness program. The focus of…
While coaching her weight management patients, Jennifer “Coop” Cooper, APRN, nurse practitioner in the office of Dr. Jonathan Kaplan, and Chief Nursing Officer at DrWell, noticed patients who switched from semaglutide to tirzepatide had better appetite suppression but an increase in food noise whereas patients on semaglutide had greater food noise reduction but less appetite…
